Akin Helps Paine Schwartz Invest in Elemental Enzymes

Akin advised Paine Schwartz Partners on the private equity firm’s strategic growth investment in Elemental Enzymes, which says it develops naturally occurring enzymes and biochemicals to protect and increase yields of commercial crops.

Akin Gump Strauss Hauer & Feld LLP said St Louis-headquartered Elemental Enzymes got counsel from Polsinelli PC. Paine Schwartz said its fourth food chain fund made the investment. Financial terms were not disclosed.

Elemental Enzymes, founded in 2011, is targeting an approximately $9 billion, biologicals segment of the crop protection market, with products to tackle problems ranging from abiotic stress to Asian soybean rust to citrus greening, ...